共 50 条
- [41] EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid TransformationCANCER CELL, 2013, 23 (05) : 677 - 692Beguelin, WendyPopovic, ReljaTeater, MattJiang, YanwenBunting, Karen L.Rosen, MonicaShen, HaoYang, Shao NingWang, LingEzponda, TeresaMartinez-Garcia, EvaZhang, HaikuoZheng, YupengVerma, Sharad K.McCabe, Michael T.Ott, Heidi M.Van Aller, Glenn S.Kruger, Ryan G.Liu, YanMcHugh, Charles F.Scott, David W.Chung, Young RockKelleher, NeilShaknovich, RitaCreasy, Caretha L.Gascoyne, Randy D.Wong, Kwok-KinCerchietti, LeandroLevine, Ross L.Abdel-Wahab, OmarLicht, Jonathan D.Elemento, OlivierMelnick, Ari M.
- [42] Functional Analysis of SRSF2 Mutations in Myelodysplastic Syndromes and Related DisordersBLOOD, 2011, 118 (21) : 743 - 743Kon, AyanaSanada, MasashiYoshida, KenichiNagata, YasunobuShiraishi, YuichiSato, YusukeSato-Otsubo, AikoYamamoto, RyoNagasaki, MasaoSuzuki, YutakaYamaguchi, TomoyukiOtsu, MakotoSugano, SumioChiba, ShigeruKoeffler, H. PhillipShih, Lee-YungNakauchi, HiromitsuMiyano, SatoruOgawa, Seishi
- [43] SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?CANCERS, 2019, 11 (08)van Poppelen, Natasha M.Drabarek, WojtekSmit, Kyra N.Vaarwater, JolandaBrands, TomParidaens, DionKilic, Eminede Klein, Annelies
- [44] EZH2 mutations in myelodysplastic/myeloproliferative neoplasmsONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 106 - 106Rinke, J.Mueller, J.Blaess, M. F.Chase, A.Schaefer, VWinkelmann, N.Haferlach, C.Cross, N. C.Hochhaus, A.Ernst, T.
- [45] EZH2 LOSS PREDISPOSES TO HETEROGENEOUS HEMATOLOGICAL MALIGNANCIESLEUKEMIA RESEARCH, 2015, 39 : S31 - S31Mochizuki-Kashio, M.Wang, C.Sashida, G.Oshima, M.Tomioka, T.Iwama, A.
- [47] CLINICAL AND BIOLOGICAL RELEVANCE OF SRSF2 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA AND THEIR COOPERATION WITH ADDITIONAL GENE MUTATIONS IN THE PROGRESSION TO SECONDARY ACUTE MYELOID LEUKEMIAHAEMATOLOGICA, 2013, 98 : 75 - 75Kuo, M.Huang, Y.Lai, C.Dunn, P.Wang, P.Wu, J.Shih, Y.Lin, T.Liang, D.Shih, L.
- [48] Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for acute leukemiaLEUKEMIA RESEARCH, 2024, 141Berton, GuillaumeSedaki, BochraCollomb, ErwannBenachour, SamiLoschi, MichaelMohty, BilalSaillard, ColombeHicheri, YosrRouzaud, CamilleMaisano, ValerioVilletard, FerdinandCorda, Evelyne D. 'IncanCharbonnier, AudeRey, JeromeHospital, Marie-AnneIttel, AntoineAbbou, NormanFanciullino, RaphaelleDadone-Montaudie, BerengereVey, NorbertVenton, GeoffroyCluzeau, ThomasAlary, Anne-SophieGarciaz, Sylvain
- [49] Substantial RUNX3 expression and co-existence with EZH2 in esophageal cancer: a new finding in Indian esophageal cancer patientsANNALS OF ONCOLOGY, 2016, 27Rehman, A. U.Iqbal, M. A.Saikia, S.Mishra, P. K.Saluja, S. S.Medhi, S.Husain, S. A.
- [50] EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsNATURE, 2012, 492 (7427) : 108 - +McCabe, Michael T.Ott, Heidi M.Ganji, GopinathKorenchuk, SusanThompson, ChristineVan Aller, Glenn S.Liu, YanGraves, Alan P.Della Pietra, Anthony, IIIDiaz, ElsieLaFrance, Louis V.Mellinger, MarkDuquenne, CelineTian, XinrongKruger, Ryan G.McHugh, Charles F.Brandt, MartinMiller, William H.Dhanak, DashyantVerma, Sharad K.Tummino, Peter J.Creasy, Caretha L.